PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.07
0.06 - 0.24
1.89M / 3.59M (Avg.)
-1.60 | -0.04
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-59.30%
Negative 5Y CAGR while YAL.AX stands at 34.25%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-30.20%
Negative 3Y CAGR while YAL.AX stands at 76.82%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
94.58%
10Y OCF/share CAGR at 75-90% of YAL.AX's 118.64%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
-105.84%
Negative 5Y OCF/share CAGR while YAL.AX is at 8.34%. Joel Greenblatt would question the firm’s operational model or cost structure.
88.82%
3Y OCF/share CAGR under 50% of YAL.AX's 363.97%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
121.88%
Net income/share CAGR 1.25-1.5x YAL.AX's 104.80%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
377.12%
Positive 5Y CAGR while YAL.AX is negative. John Neff might view this as a strong mid-term relative advantage.
149.43%
Below 50% of YAL.AX's 426.61%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
-87.09%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
105.50%
5Y equity/share CAGR above 1.5x YAL.AX's 39.50%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
539.08%
3Y equity/share CAGR above 1.5x YAL.AX's 62.07%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.